by Sue Robbins | Oct 9, 2014 | Headache Drugs
A new phase 2 trial of ALD403, a humanized monoclonal antibody directed against calcitonin gene-related peptide (CGRO) showed that the drug was safe and effective. Although preliminary, the results are promising, said lead author, David W. Dodick, professor,...
by Sue Robbins | Oct 8, 2014 | Headache Drugs
Zogenix, the maker of the opioid painkiller Zohydro ER recently submitted an application to the Food and Drug Administration for a new version that the company says will be less susceptible to abuse. The new formulation “contains additional inactive ingredients...
by Sue Robbins | Oct 7, 2014 | Headache Drugs
Can the bounty of apples available this time of year be good for the waistline? A study of over 55 adults published in the journal Appetite revealed that eating an apple before lunch helped reduce calories in that meal by 15% or about 185 calories. The researchers...
by Sue Robbins | Oct 3, 2014 | Headache Drugs
There are some compounding pharmacies that prepare compounded pain creams and ointments that contain a combination of potent medications. Many include drugs that can cause central nervous system depression or cardiac effects such as ketamine, gabapentin, clonidine,...
by Sue Robbins | Sep 29, 2014 | Headache Drugs
There was an article on Reuters website recently that suggests walking may be the best exercise out there. Here is part of the article that explains why… Walking may never become as trendy as CrossFit, as sexy as mud runs or as ego-boosting as Ironman races but...
by Sue Robbins | Sep 25, 2014 | Headache Drugs
“Mast cell degranulation or parasympathetic hyperactivity, as encountered with asthma, might predispose an individual to the future onset of chronic migraine,” said Vincent Martin, MD, Professor of Medicine at the University of Cincinnati. The findings are...
